Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

URL of this page: https://medlineplus.gov/genetics/gene/nsdhl/

NSDHL gene

NAD(P) dependent steroid dehydrogenase-like

Normal Function

The NSDHL gene provides instructions for making an enzyme that is involved in the production (synthesis) of cholesterol. Cholesterol is a lipid (fat) that is obtained from foods that come from animals, particularly egg yolks, meat, and dairy products. The body can also make its own cholesterol. During cholesterol synthesis, the NSDHL enzyme participates in one of several steps that convert a molecule called lanosterol to cholesterol. Specifically, the NSDHL enzyme is part of an enzyme complex that removes a carbon atom and three hydrogen atoms (a methyl group) from lanosterol.

Although high cholesterol levels are a well-known risk factor for heart disease, the body needs some cholesterol to develop and function normally. Before birth, cholesterol interacts with signaling proteins that control the early development of the brain, limbs, genital tract, and other structures. It is also an important component of cell membranes and myelin, the fatty covering that insulates nerve cells. Additionally, cholesterol is used to make certain hormones and is important for the production of acids that are used in digestion (bile acids).

Health Conditions Related to Genetic Changes

CHILD syndrome

Several variants (also called mutations) in the NSDHL gene have been found to cause CHILD syndrome, a condition that can affect the development of the arms, legs, and other parts of the body. The signs and symptoms of this disorder are typically limited to only one side of the body.

Most of the variants in the NSDHL gene change single protein building blocks (amino acids) in the NSDHL enzyme.  A few other variants delete part or all of the NSDHL gene. Many of these variants prevent the production of any functional NSDHL enzyme, which disrupts the normal synthesis of cholesterol within cells. A shortage of this enzyme may also allow potentially toxic byproducts of cholesterol synthesis to build up in the body's tissues. Researchers suspect that low cholesterol levels can contribute to problems with the growth and development of many parts of the body. It is not known, however, exactly how a disturbance in cholesterol synthesis leads to the specific features of CHILD syndrome.

More About This Health Condition

Other Disorders

Variants in the NSDHL gene can cause CK syndrome, a condition characterized by intellectual disabilities and behavior problems in people with one X chromosome (typical of males). Additional symptoms may include seizures, a small head size (microcephaly), and brain abnormalities. People with two X chromosomes (typical of females) who have a variant that causes CK syndrome are typically unaffected; however, some may experience mild behavior problems such as irritability or aggression. CK syndrome is very rare; fewer than 30 people with this condition have been reported in the medical literature.

Other Names for This Gene

  • H105e3
  • SDR31E1
  • XAP104

Additional Information & Resources

Tests Listed in the Genetic Testing Registry

Scientific Articles on PubMed

Catalog of Genes and Diseases from OMIM

Gene and Variant Databases

References

  • Bornholdt D, Konig A, Happle R, Leveleki L, Bittar M, Danarti R, Vahlquist A, Tilgen W, Reinhold U, Poiares Baptista A, Grosshans E, Vabres P, Niiyama S, Sasaoka K, Tanaka T, Meiss AL, Treadwell PA, Lambert D, Camacho F, Grzeschik KH. Mutational spectrum of NSDHL in CHILD syndrome. J Med Genet. 2005 Feb;42(2):e17. doi: 10.1136/jmg.2004.024448. No abstract available. Citation on PubMed or Free article on PubMed Central
  • Caldas H, Herman GE. NSDHL, an enzyme involved in cholesterol biosynthesis, traffics through the Golgi and accumulates on ER membranes and on the surface of lipid droplets. Hum Mol Genet. 2003 Nov 15;12(22):2981-91. doi: 10.1093/hmg/ddg321. Epub 2003 Sep 23. Citation on PubMed
  • du Souich C, Raymond FL, Grzeschik KH, Boerkoel CF. NSDHL-Related Disorders. 2011 Feb 1 [updated 2018 Oct 25]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from http://www.ncbi.nlm.nih.gov/books/NBK51754/ Citation on PubMed
  • Konig A, Happle R, Bornholdt D, Engel H, Grzeschik KH. Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome. Am J Med Genet. 2000 Feb 14;90(4):339-46. Citation on PubMed
  • Porter FD, Herman GE. Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res. 2011 Jan;52(1):6-34. doi: 10.1194/jlr.R009548. Epub 2010 Oct 7. Citation on PubMed or Free article on PubMed Central
  • Porter FD. Human malformation syndromes due to inborn errors of cholesterol synthesis. Curr Opin Pediatr. 2003 Dec;15(6):607-13. doi: 10.1097/00008480-200312000-00011. Citation on PubMed
  • Ramphul K, Kota V, Sathe NC, Mejias SG. CHILD Syndrome. 2024 Feb 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK507813/ Citation on PubMed

The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.